Eagle Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.92M | Sell |
709,518
-132,053
| -16% | -$729K | 0.02% | 413 |
|
|
2024
Q2 | $2.74M | Sell |
841,571
-126,244
| -13% | -$410K | 0.01% | 444 |
|
|
2024
Q1 | $3.16M | Sell |
967,815
-42,519
| -4% | -$139K | 0.02% | 435 |
|
|
2023
Q4 | $3.55M | Sell |
1,010,334
-32,061
| -3% | -$113K | 0.02% | 413 |
|
|
2023
Q3 | $6.96M | Sell |
1,042,395
-16,151
| -2% | -$108K | 0.04% | 315 |
|
|
2023
Q2 | $8.88M | Sell |
1,058,546
-785,464
| -43% | -$6.59M | 0.05% | 278 |
|
|
2023
Q1 | $18.3M | Buy |
1,844,010
+72,321
| +4% | +$718K | 0.11% | 171 |
|
|
2022
Q4 | $12.3M | Buy |
1,771,689
+313,681
| +22% | +$2.18M | 0.08% | 212 |
|
|
2022
Q3 | $7.79M | Sell |
1,458,008
-47,930
| -3% | -$256K | 0.05% | 272 |
|
|
2022
Q2 | $6.01M | Buy |
1,505,938
+32,479
| +2% | +$130K | 0.04% | 321 |
|
|
2022
Q1 | $6.55M | Buy |
1,473,459
+80,523
| +6% | +$358K | 0.03% | 346 |
|
|
2021
Q4 | $5.66M | Buy |
1,392,936
+46,468
| +3% | +$189K | 0.02% | 389 |
|
|
2021
Q3 | $11.8M | Buy |
1,346,468
+260,950
| +24% | +$2.29M | 0.05% | 282 |
|
|
2021
Q2 | $12.3M | Buy |
+1,085,518
| New | +$12.3M | 0.05% | 285 |
|